DETECTION OF P53 EXPRESSION AND S-PHASE CELL FRACTION IN PARAFFIN-EMBEDDED TISSUE BY A DOUBLE-LABELING TECHNIQUE

被引:1
作者
BENINI, E [1 ]
SILVESTRINI, R [1 ]
DAIDONE, MG [1 ]
CANOVA, S [1 ]
机构
[1] IST NAZL STUDIO & CURA TUMORI,I-20133 MILAN,ITALY
关键词
DOUBLE LABELING; P53; EXPRESSION; CELL PROLIFERATION; HUMAN BREAST CANCER;
D O I
10.1177/43.10.7560890
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
TP53 is a gene that normally regulates cell growth and division, Alterations to it may induce a proliferative advantage and confer an aggressive phenotype, In breast cancer, we observed a poor correlation (r(s) = 0.17) between P53 expression and proliferative activity evaluated as [H-3]-thymidine ([H-3]-dT) labeling index and an independent prognostic relevance of the two variables. We used a double-labeling technique to simultaneously evaluate the fraction of P53-positive and [H-3]-dT-labeled cells to analyte the degree of association between the two markers on individual cells in order to understand their biological significance, The study was performed on a series of 44 P53-positive (P53(+)) breast cancers. Histological sections were immunostained for P53 with monoclonal antibody (MAb) PAb1801 and then processed for autoradiography. A weak direct relation between P53 positivity and [H-3]-dT incorporation (r(s) = 0.4) was observed on the overall series of P53(+) tumors and was maintained in subgroups defined by several biological and pathological features, except for estrogen receptor-negative tumors, The simultaneous presence of P53 expression and [H-3]-dT incorporation was directly and significantly proportional to the fraction of S-phase cells of the tumor (r(s) = 0.7). Conversely, the fraction of cells expressing only P53 was inversely related to cell proliferation (r(s) = -0.66). These findings support the hypothesis that P53 has biological functions other than cell cycle regulation.
引用
收藏
页码:999 / 1003
页数:5
相关论文
共 19 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]  
BENINI E, 1993, INT J ONCOL, V3, P817
[3]  
BHARGAVA V, 1994, MODERN PATHOL, V7, P361
[4]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[5]   LOSS OF HETEROZYGOSITY ON THE SHORT ARM OF CHROMOSOME-17 IS ASSOCIATED WITH HIGH PROLIFERATIVE CAPACITY AND DNA ANEUPLOIDY IN PRIMARY HUMAN BREAST-CANCER [J].
CHEN, LC ;
NEUBAUER, A ;
KURISU, W ;
WALDMAN, FM ;
LJUNG, BM ;
GOODSON, W ;
GOLDMAN, ES ;
MOORE, D ;
BALAZS, M ;
LIU, E ;
MAYALL, BH ;
SMITH, HS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :3847-3851
[6]   P53 AND BEHAVIOR OF COLORECTAL-CANCER [J].
GOH, HS ;
CHAN, CS ;
KHINE, K ;
SMITH, DR .
LANCET, 1994, 344 (8917) :233-234
[7]  
HOLLSTEIN M, 1991, SCIENCE, V353, P49
[8]   THE 1993 WALTER-HUBERT-LECTURE - THE ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN TUMORIGENESIS [J].
LEVINE, AJ ;
PERRY, ME ;
CHANG, A ;
SILVER, A ;
DITTMER, D ;
WU, M ;
WELSH, D .
BRITISH JOURNAL OF CANCER, 1994, 69 (03) :409-416
[9]  
LI ZH, 1994, AM J PATHOL, V144, P303
[10]  
MARKS JR, 1991, CANCER RES, V51, P2979